Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Hautklinik der Johannes Gutenberg-Universität Mainz.
Malignant melanoma is a fatal disease in its terminal stage. Despite of all attempts to prolong the life of the patient with chemo- or chemoimmunotherapies, the course of the disease is rarely affected. Specific immunotherapies with antigen-pulsed DC might be a reason for optimism. DC are professional antigen-presenting cells with a capability to process and present melanoma antigens. First vaccination studies show encouraging results with complete remissions even in progressed cases.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on